2025
Genetically proxied tumour necrosis factor inhibition and pregnancy-related maternal and foetal outcomes in the general population: a Mendelian randomization study
Zhao S, Woolf B, Rogne T, Gill D. Genetically proxied tumour necrosis factor inhibition and pregnancy-related maternal and foetal outcomes in the general population: a Mendelian randomization study. Rheumatology Advances In Practice 2025, 9: rkaf100. PMID: 40937292, PMCID: PMC12422557, DOI: 10.1093/rap/rkaf100.Peer-Reviewed Original ResearchPregnancy-related outcomesRisk of gestational diabetesTNF inhibitorsGestational diabetesAssociated with lower riskFoetal outcomesPre-eclampsiaPreterm birthSpontaneous abortionHyperemesis gravidarumPregnancy-relatedLow risk of gestational diabetesOutcome of spontaneous abortionRate of preterm deliverySafety of TNF inhibitorsTumor necrosis factor inhibitionAdverse pregnancy-related outcomesAt-risk pregnant womenAssociated with CRPPreterm deliveryEctopic pregnancyGenetic confoundingPregnant womenRandomized studyFactor inhibition
2014
Association between low blood glucose increase during glucose tolerance tests in pregnancy and impaired fetal growth
Rogne T, Jacobsen GW. Association between low blood glucose increase during glucose tolerance tests in pregnancy and impaired fetal growth. Acta Obstetricia Et Gynecologica Scandinavica 2014, 93: 1160-1169. PMID: 24576054, DOI: 10.1111/aogs.12365.Peer-Reviewed Original ResearchConceptsGlucose tolerance testFetal growthFetal weightTolerance testGlucose challengeWeek 25Oral glucose tolerance testMaternal blood glucoseLow groupProspective cohort studyGestational week 25Low-risk populationOral glucose challengeHigh-risk populationBlood glucose increaseCapillary glucose valuesPoisson regression modelsLighter babiesCohort studyPregnant womenBlood glucoseLate pregnancyLight fetusesWeek 37Anthropometric measures
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply